Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
about
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation ResistanceMouse models in the era of large human tumour sequencing studiesDefective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
P2860
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
@en
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
@nl
type
label
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
@en
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
@nl
prefLabel
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
@en
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
@nl
P2093
P2860
P50
P356
P1433
P1476
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
@en
P2093
Alex Strong
Andreas Arbeiter
Barbara Seidler
Beiyuan Fu
Björn Konukiewitz
Christian Veltkamp
Dieter Saur
Fengtang Yang
Fernando Constantino-Casas
Günter Schneider
P2860
P2888
P356
10.1038/NATURE25459
P407
P50
P577
2018-01-24T00:00:00Z